Search
-
Futurapolis Santé 2023: New feats of health science
The Futurapolis Santé health event returns to Montpellier on October 13-14, 2023, at the Opéra Comédie building.
-
Euro-Africa Montpellier WATER DAYS
Montpellier Méditerranée Métropole, MedVallée, and the ICIREWARD UNESCO Water Centre invite you to the first edition of the Euro-Africa Montpellier Water Days on October 9 and 10, 2023.
-
Euro-Africa Montpellier Biennial
Following the success of the Africa-France Summit, Montpellier is proud to host and co-organize the first Euro-Africa Biennial in the fall of 2023. It will be a key week for bringing together the E...
-
SPECIFIC POLYMERS, 20 years supporting sustainable innovation
The SPECIFIC POLYMERS research center, celebrating its 20th anniversary on June 8 at Domaine Décalage in Saint Aunès, is taking a decisive step forward by applying its unique expertise to new energ...
-
Sim&Cure, helping prevent brain aneurysm rupture
With its Sim&Size, Sim&Treat, and Sim&Predict software solutions, the Montpellier startup wants to cover the entire patient journey by personalizing the therapeutic approach. The compan...
-
The MedVallée roadmap respected to the letter
Just ten months after its official launch, the MedVallée excellence hub in global health has already started working on 19 of its 30 assigned actions. Ten of those have already been completed. The ...
-
Montpellier selected for University-Hospital Institute dedicated to autoimmune diseases
As part of Plan France 2030, Montpellier has been chosen to host “Immun4Cure”, a University-Hospital Institute (IHU) dedicated to autoimmune diseases and innovative immunotherapies.
-
This year’s AFSSI Life Sciences event will be held in Montpellier
In partnership with MedVallée, Eurobiomed, and AD’OCC, AFSSI is organizing the 10th edition of AFSSI Connections in Montpellier, a truly French annual marketplace for Life Science R&D.
-
Medincell : historical succes in the heart of MedVallée
MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.
-
Medincell: historical success in the heart of MedVallée
MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.
